Protara Therapeutics (TARA) Assets Average (2014 - 2026)

Protara Therapeutics' Assets Average history runs 13 years deep, the most recent figure standing at $200.7 million for Q1 2026.

• In Q1 2026, Assets Average rose 14.68% year-over-year to $200.7 million; the TTM figure through Mar 2026 stood at $200.7 million (up 14.68% YoY), while the FY2025 annual figure was $195.5 million, up 50.12% from the prior year.
• Assets Average was $200.7 million for Q1 2026 at Protara Therapeutics, up from $177.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $200.7 million in Q1 2026 to a low of $73.5 million in Q1 2024.
• Historically, Assets Average has averaged $132.6 million across 5 years, with a median of $137.8 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Assets Average plunged 39.5% in 2023, then jumped 137.96% in 2025.
• A 5-year view of Assets Average shows it stood at $130.9 million in 2022, then tumbled by 36.07% to $83.7 million in 2023, then surged by 64.58% to $137.8 million in 2024, then grew by 28.51% to $177.1 million in 2025, then climbed by 13.35% to $200.7 million in 2026.
• The last three Assets Average figures came in at $200.7 million (Q1 2026), $177.1 million (Q4 2025), and $150.8 million (Q3 2025), per Business Quant data.